Medivir amends rights offering

Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Infectious, Autoimmune, Musculoskeletal Date announced: 4/27/10 Type: Rights offering To be raised: SEK325.1 million ($45.2 million) Shares: 5.2 mil...